NovoCure Limited

NASDAQ:NVCR

18.79 (USD) • At close July 24, 2024
Bedrijfsnaam NovoCure Limited
Symbool NVCR
Munteenheid USD
Prijs 18.79
Beurswaarde 2,022,010,690
Dividendpercentage 0%
52-weken bereik 10.87 - 41.51
Industrie Medical Instruments & Supplies
Sector Healthcare
CEO Mr. Asaf Danziger
Website https://www.novocure.com

An error occurred while fetching data.

Over NovoCure Limited

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optune

Vergelijkbare Aandelen

Masimo Corporation logo

Masimo Corporation

MASI

109.27 USD

Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc.

NBIX

145.88 USD

DENTSPLY SIRONA Inc. logo

DENTSPLY SIRONA Inc.

XRAY

26.24 USD

Repligen Corporation logo

Repligen Corporation

RGEN

131.39 USD

Exact Sciences Corporation logo

Exact Sciences Corporation

EXAS

47.85 USD

Bruker Corporation logo

Bruker Corporation

BRKR

64.08 USD

Maravai LifeSciences Holdings, Inc. logo

Maravai LifeSciences Holdings, Inc.

MRVI

8.28 USD

Acadia Healthcare Company, Inc. logo

Acadia Healthcare Company, Inc.

ACHC

66.28 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)